What is a Tandem Transplant?

There are two main types of stem cell transplantations in the treatment of some blood cancers, and it comes down to whether the transplanted cells are yours, or someone else's.

When the cells are your own, it is called an autologous stem cell transplant. When the cells are someone else's, it is called an allogeneic stem cell transplant.

From there, stem cell transplants can be further divided a little bit depending on a couple of factors. One of those subtypes is called a tandem transplant.

Tandem Transplants

In a tandem transplant, a patient undergoes two autologous stem cell transplants back to back, in a row. This usually involves two corresponding courses of high-dose chemotherapy with the stem cell transplant following the completion of each chemo course.

Prior to beginning the first transplant, the patient's own stem cells are harvested. For each of the two transplants, the patient receives half of the collected cells.

Because the high-dose chemotherapy is so tough on the body, the courses are separated by no more than six months. Just as the patient recovers from the first transplant, the second one begins.

Tandem Transplants: Use

According to the American Cancer Society, tandem transplants are:

" ... most often used to treat multiple myeloma and advanced testicular cancer, but doctors do not always agree that these are really better than a single transplant for certain cancers. Because this involves 2 transplants, the risk of serious outcomes is higher than for a single transplant. Tandem transplants are still being studied to find out when they might be best used."

The ACS also notes that sometimes, a tandem transplant refers to a patient undergoing both an autologous transplant and then an allogeneic transplant.

Source: American Cancer Society

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap